Botox 100 IU (OnabotulinumtoxinA) by Allergan Aesthetics.
Indications: Temporary improvement in the appearance of moderate to severe glabellar (frown) lines, lateral canthal (crow's feet) lines and forehead lines. Therapeutic indications per local SmPC include chronic migraine prophylaxis, cervical dystonia, blepharospasm, focal spasticity, primary axillary hyperhidrosis and overactive bladder.
Administration: Intramuscular or intradermal injection by a trained practitioner. Typical aesthetic dosing: glabellar lines 20 units divided across 5 injection points (4 units each). Units are not interchangeable with other botulinum toxin products.
Storage: Store unopened vials refrigerated at 2–8 °C. Use reconstituted solution within 24 hours (refrigerated).
Prescription-only medicine (POM). Supplied to licensed healthcare professionals only.
| Manufacturer | Allergan Aesthetics (an AbbVie company) |
| Active ingredient | OnabotulinumtoxinA (Botulinum toxin type A, Clostridium botulinum) 100 Allergan units; excipients: human albumin, sodium chloride. |
| Strength & pack | 1 vial of 100 units, vacuum-dried powder for solution for injection. |
| Form | Powder for solution for injection (lyophilised), reconstitute with sterile unpreserved 0.9% sodium chloride |
| Storage | Store unopened vials refrigerated at 2–8 °C. Use reconstituted solution within 24 hours (refrigerated). |
| Regulatory status | Prescription-only medicine (POM). Supplied to licensed healthcare professionals only. |